Do newer drugs treat fewer diseases, controlling for time since launch? Evidence from France and the U.S.

J Pharm Policy Pract · 2024 · PMC11188943 · PMID 38903694

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The coefficient on this variable (β 1 ) is negative and highly significant, indicating that later-vintage drugs tended to have fewer indications.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.